Mesenchymal stem cells for fistulising Crohn's disease (Q88033153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Mesenchymal stem cells for fistulising Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

main subject

mesenchymal stem cell

1 reference

1 reference

Rachele Ciccocioppo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Gino Roberto Corazza

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

29 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

number of pages

2

1 reference

inferred from page(s)

published in

The Lancet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

10051

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

1251-1252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931209-0

7 January 2021

10.1016/S0140-6736(16)31209-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477895%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference